ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

No reported Research & Development figures are available to summarize.

Research & Development history

Currency unavailable · from the income statement

No Research & Development data reported for this period type.

Research & Development vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Research & Development for ADRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WVEWave Life Sciences Ltd.LTM Mar 2026$189.6M USD+13.6%+16.4%264.1%
PRMEPrime Medicine, Inc.LTM Mar 2026$154.18M USD-2.5%+22.8%3822.0%
STOKStoke Therapeutics, Inc.LTM Mar 2026$144.07M USD+45.7%+21.0%449.1%
MGTXMeiraGTx Holdings plcLTM Mar 2026$128.82M USD+9.2%+14.8%161.5%
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026$98.25M USD-44.3%-8.8%216.6%
SLNSilence Therapeutics plcLTM Mar 2026$61.84M USD—+24.0%6710.8%
RNAAtrium Therapeutics, Inc.FY2025$53.76M USD——288.7%
PRQRProQR Therapeutics N.V.LTM Mar 2026€44.34M EUR+12.6%-7.1%329.9%
BNTCBenitec Biopharma Inc.LTM Mar 2026$19.2M USD+1.2%+17.6%—
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —+9.2%+17.0%309.3%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.